Literature DB >> 7304556

Breast cancer incidence in women with a history of progesterone deficiency.

L D Cowan, L Gordis, J A Tonascia, G S Jones.   

Abstract

In order to investigate the nature of the association of involuntarily delayed first birth and risk of breast cancer, 1083 white women who had been evaluated and treated for infertility from 1945-1965 were followed prospectively through April 1978 to ascertain their breast cancer incidence. These women were categorized as to the cause of infertility into two groups, those with endogenous progesterone deficiency (PD) and those with nonhormonal causes (NH). Women in the PD group had 5.4 times the risk of premenopausal breast cancer compared to women in the NH group. This excess risk could not be explained by differences between the two groups in ages at menarche or menopause, history of oral contraceptive use, history of benign breast disease or age at first birth. Women in the PD group also experienced a 10-fold increase in deaths from all malignant neoplasms compared to the NH group. The incidence of postmenopausal breast cancer did not differ significantly between the two groups.

Entities:  

Keywords:  Biology; Breast Cancer; Cancer; Corpus Luteum Hormones; Data Collection; Diseases; Endocrine System; Hormones; Incidence; Infertility; Measurement; Menarche; Menopause; Neoplasms; Physiology; Population At Risk; Progestational Hormones; Progesterone--analysis; Prospective Studies; Reproduction; Research Methodology; Studies; Urogenital Effects; Urogenital System

Mesh:

Substances:

Year:  1981        PMID: 7304556     DOI: 10.1093/oxfordjournals.aje.a113184

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis.

Authors:  B Formby; T S Wiley
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Risk factors for breast cancer. Pollutants and pesticides may be important.

Authors:  P J Lewis
Journal:  BMJ       Date:  1994-12-17

3.  Risk factors for breast cancer.

Authors:  K McPherson; C M Steel; J M Dixon; W R Miller
Journal:  BMJ       Date:  1995-03-04

4.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Luteal phase defect and breast cancer genesis.

Authors:  P Mauvais-Jarvis; R Sitruk-Ware; F Kuttenn
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

6.  Medical management of premenstrual syndrome.

Authors:  C Dean; S K Steinberg; W H Sylvester
Journal:  Can Fam Physician       Date:  1986-04       Impact factor: 3.275

7.  Body size and breast cancer in a black population--the Barbados National Cancer Study.

Authors:  Barbara Nemesure; Suh-Yuh Wu; Anselm Hennis; M Cristina Leske
Journal:  Cancer Causes Control       Date:  2008-11-06       Impact factor: 2.506

8.  Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women's Health Study.

Authors:  T A Sellers; J D Potter; R K Severson; R M Bostick; C L Nelson; L H Kushi; A R Folsom
Journal:  Cancer Causes Control       Date:  1993-01       Impact factor: 2.506

9.  Gonadal steroids in athletic women contraception, complications and performance.

Authors:  J C Prior; Y Vigna
Journal:  Sports Med       Date:  1985 Jul-Aug       Impact factor: 11.136

10.  Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study.

Authors:  Jayeon Kim; Jennifer E Mersereau; Nikhil Khankari; Patrick T Bradshaw; Lauren E McCullough; Rebecca Cleveland; Sumitra Shantakumar; Susan L Teitelbuam; Alfred I Neugut; Ruby T Senie; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2016-01-21       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.